Lighthouse, in cooperation with the University Heidelberg Public Health Institute and the
University Köln (Cologne) would like to set up a cohort to study baseline characteristics and
long-term clinical outcomes of patients using Tenofovir based Antiretroviral Therapy at the
Lighthouse. As of March 2014, patients above 18 years and giving informed consent coming to
the Lighthouse to newly initiate ART will be approached to enroll in the cohort.
The results will be disseminated both nationally at the Ministry of Health Technical Working
Group (TWG), at the annual Research Dissemination and Best Practices conferences of the
College of Medicine and National AIDS Commission as well as internationally. The results will
also be written up for publication in appropriate peer-reviewed journals.
Details
Lead Sponsor:
Lighthouse Trust
Collaborators:
Heidelberg University Ministry of Health, Malawi University of Cologne